Short Interest in Zepp

Zepp Health Co. (NYSE:ZEPPGet Rating) saw a significant decline in short interest during the month of July. As of July 15th, there was short interest totaling 217,400 shares, a decline of 29.0% from the June 30th total of 306,300 shares. Based on an average daily trading volume, of 136,700 shares, the short-interest ratio is presently 1.6 days. Approximately 0.7% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Separately, TheStreet cut Zepp Health from a “c-” rating to a “d+” rating in a research report on Monday, June 13th.

Zepp Health Price Performance

NYSE ZEPP opened at $1.74 on Friday. Zepp Health has a twelve month low of $1.69 and a twelve month high of $11.83. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.98 and a current ratio of 1.69. The stock has a market capitalization of $109.27 million, a PE ratio of 8.70 and a beta of 0.98. The stock has a 50-day simple moving average of $1.92 and a 200 day simple moving average of $2.88.

Zepp Health (NYSE:ZEPPGet Rating) last posted its quarterly earnings data on Tuesday, May 24th. The company reported ($0.22) earnings per share for the quarter. Zepp Health had a return on equity of 3.05% and a net margin of 1.50%. The business had revenue of $119.42 million for the quarter.

Hedge Funds Weigh In On Zepp Health

Large investors have recently made changes to their positions in the business. Allspring Global Investments Holdings LLC bought a new position in Zepp Health during the fourth quarter valued at about $29,456,000. BlackRock Inc. increased its stake in Zepp Health by 1.2% during the first quarter. BlackRock Inc. now owns 612,416 shares of the company’s stock valued at $1,764,000 after acquiring an additional 7,427 shares during the period. State Street Corp increased its stake in Zepp Health by 7.7% during the first quarter. State Street Corp now owns 283,391 shares of the company’s stock valued at $844,000 after acquiring an additional 20,382 shares during the period. Dimensional Fund Advisors LP increased its stake in Zepp Health by 25.0% during the first quarter. Dimensional Fund Advisors LP now owns 189,774 shares of the company’s stock valued at $547,000 after acquiring an additional 37,952 shares during the period. Finally, Invesco Ltd. increased its stake in Zepp Health by 58.9% during the first quarter. Invesco Ltd. now owns 43,383 shares of the company’s stock valued at $125,000 after acquiring an additional 16,087 shares during the period. Institutional investors and hedge funds own 54.16% of the company’s stock.

About Zepp Health

(Get Rating)

Zepp Health Corporation, together with its subsidiaries, develops, manufactures. Sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products. Self-Branded Products and Others. The company offers smart bands, watches. Scales. Smart hearable products, home treadmill, sportswear, home appliances. Smart watch accessories under the Xiaomi and Amazfit brands.

Featured Stories

Receive News & Ratings for Zepp Health Daily –. Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.

You may also like

You May Also Like